NCR2 and neoplasm: Melanoma and the melanoma tumor microenvironment secret immunosuppressive molecules and factors such as IDO, PGE2, TGF-β, prostaglandins, and IL-10, which can downmodulate NK cell-activating receptors and can inhibit NK cell activity [34,78].